Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12
Closed -$331 – 647
2026
Q2
$331 Buy
+12
New +$265 ﹤0.01% 578
2023
Q2
– Sell
-70
Closed -$1.27K – 567
2023
Q1
$1.27K Hold
70
– – ﹤0.01% 560
2022
Q4
$1.2K Buy
+70
New +$1.24K ﹤0.01% 580

Other funds holding RXO

Mascoma Wealth Management's RXO Position: Q3 2026 in Review

Mascoma Wealth Management sold out of RXO (RXO) in Q3 2026, closing a stake of 12 shares — an estimated $331 sold.

Mascoma Wealth Management first reported a position in RXO in Q4 2022 and held it in 3 quarters. The position peaked at $1.27K in Q1 2023. 46 funds tracked by Wall St. Rank hold RXO as of Q3 2026.

  • Mascoma Wealth Management reported no remaining RXO position as of Q3 2026 after selling out during the quarter.
  • Mascoma Wealth Management sold 12 RXO shares in Q3 2026, an estimated $331.
  • Mascoma Wealth Management first reported a position in RXO in Q4 2022 and held it in 3 quarters.
  • Mascoma Wealth Management's RXO position peaked at $1.27K in Q1 2023.
  • 46 funds tracked by Wall St. Rank held RXO as of Q3 2026.

Based on Mascoma Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.